ACC-010

N/A

Report date: 2022/12/09 19:21:51
NME

Base Information

Drug NameACC-010
Drug Alias NameACC-010ACC010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsPostoperative inflammationInflammationLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Accelas Pharmaceutical Co LtdJiangsu Aidea Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsPostoperative inflammationInflammation
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A